Mayinglong Pharmaceutical Group Co., Ltd. (600993.SS) Stock Price & Growth Analysis

Quote Panel

Updated July 12, 2025

1W 1.58 % 1M -3.32 % 3M 4.29 % 1Y 6.54 %

Key Metrics

Market Cap
11.94B
Shares Outstanding
431.05M
Share in Float
268.64M
Dividende
0.4

Earning Date
No Data
Price Target
27.7
Average Volume
5.92M
Beta
0.406

Range
21.33-31.46
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.mayinglong.cn
Sector
Healthcare

Quote Panel

Updated July 12, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

22.40x

P/E Ratio

3.19x

P/S Ratio

2.81x

P/B Ratio

0.0

Debt/Equity

14.3%

Net Margin

$1.2

EPS

How 600993.SS compares to sector?

P/E Ratio

Fundamentals

Relative Strength

600993.SS

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

600993.SS

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$5B

407%

2026-Revenue

$1.77

276%

2026-EPS

$952M

284%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q4.22

-37%

0.15
vs 0.23

Q1.23

-53%

0.15
vs 0.32

Q2.23

-30%

0.22
vs 0.31

Q3.23

-4%

0.32
vs 0.33

Q4.23

-60%

0.06
vs 0.15

Q1.24

+206%

0.46
vs 0.15

Q2.24

+22%

0.27
vs 0.22

Q3.24

+6%

0.34
vs 0.32

Q4.24

+184%

0.16
vs 0.06

Q1.25

+2%

0.47
vs 0.46

Sales Growth

YoY

Current

Estimates

Q4.22

-13%

747.3M vs 854.8M

Q1.23

-12%

832.7M vs 949.1M

Q2.23

-17%

807.7M vs 978.7M

Q3.23

-6%

805.9M vs 857.3M

Q4.23

-8%

690.5M vs 747.3M

Q1.24

+14%

945.4M vs 832.7M

Q2.24

+20%

968.7M vs 807.7M

Q3.24

+7%

864.1M vs 805.9M

Q4.24

+36%

936.2M vs 690.5M

Q1.25

+3%

969.1M vs 945.4M

Return on Equity

QoQ

Q2.23

+3%

0.03
vs 0.05

Q3.23

+4%

0.04
vs 0.03

Q4.23

+1%

0.01
vs 0.04

Q1.24

+5%

0.05
vs 0.01

Q2.24

+3%

0.03
vs 0.05

Q3.24

+4%

0.04
vs 0.03

Q4.24

+2%

0.02
vs 0.04

Q1.25

+5%

0.05
vs 0.02

Institutionnal Ownership

Earnings Growth

Quote Panel

Updated July 12, 2025

1W 1.58 % 1M -3.32 % 3M 4.29 % 1Y 6.54 %

Key Metrics

Market Cap
11.94B
Shares Outstanding
431.05M
Share in Float
268.64M
Dividende
0.4

Earning Date
No Data
Price Target
27.7
Average Volume
5.92M
Beta
0.406

Range
21.33-31.46
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.mayinglong.cn
Sector
Healthcare

Company Description